OHRP COVID-19 Guidance

The Office for Human Research Protections (OHRP) has provided guidance on COVID-19.  Read More >>

Read More >>

Updated FDA Guidance for COVID19

The FDA has issued the following guidance on the conduct of clinical trials of medical products during the COVID-19 pandemic.

Read More >>

Notification to Clients: COVID-19 Policy Exception Statement

Salus IRB issues policy exception statement for reviewing study modifications due to COVID-19.

Read More >>